Search

everythinglearnresearchcommunity

for

Search:↓

Squalene-based carriers improve delivery of a treatment to hair follicles for alopecia areata.

The document concludes that mouse models are crucial for studying hair biology and that all mutant mice may have hair growth abnormalities that require detailed analysis to identify.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Kids with alopecia areata may experience more stress but not necessarily feel more anxious or depressed than others.

Surface Plasmon Resonance is a useful tool for studying protein interactions and has potential for future technological advancements.

Psoriasis can cause temporary or permanent hair loss.

Use finasteride, minoxidil, and follicular unit transplantation for hair loss treatment.

A woman's total hair loss from hepatitis C treatment grew back after stopping the medication.

Oral contraceptives can cause skin issues like dark patches, acne, yeast infections, sensitivity to light, spider veins, skin rashes, and hair loss.

Antimicrobial lotion reduces inflammation and increases hair density in hair loss patients.

Tiny particles called extracellular vesicles could help with skin healing and hair growth, but more research is needed.

Hair loss in mice starts with immune cells damaging hair roots before it becomes visible.

Leflunomide and methotrexate are equally effective for rheumatoid arthritis but have different side effects.

Minoxidil-loaded liposomes effectively deliver to hair follicles, potentially improving hair growth and treating alopecia.

STAT5 activation is crucial for starting the hair growth phase.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

Hair follicles on the scalp interact with and respond to the nervous system, influencing their own behavior and growth.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Activating NRF2 might help treat hair disorders by improving antioxidant defenses.

Trichoscopy is useful for diagnosing and monitoring systemic lupus erythematosus, with certain hair and scalp changes indicating more active disease.

Higher caspase-1 levels found in balding scalps; reducing it may help treat hair loss.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

Antidepressants might help with skin inflammation and improve conditions like psoriasis and eczema.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Vesicular carriers like liposomes may improve cosmetic skin treatment delivery and effectiveness but need more human research.

FoxN1 gene is essential for proper thymus structure and preventing hair loss.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.